🚨🚨New paper alert 🚨🚨
nature.com/articles/s42255-0…
rdcu.be/dVak3
We enable the community to query and visualise our results interactively through our webserver: omicscience.org/apps/protdet…
Huge thanks to @Julia_Czs @pietznerm @BurulcaU @KopruluMine @KastenmullerLab @Julian_H0ffmann and many others!
@QMULBartsTheLon @MRC_Epid @berlinnovation
Want to get a summary of our paper and of the implications of our research? Check out our research briefing at @NatureMedicine
nature.com/articles/s41591-0…
Precision medicine requires finding people at a high risk of disease.
We used >3,000 proteins to develop sparse models for prediction of future risk of 218 diseases using #EHRs and #MachineLearning in @uk_biobank.
nature.com/articles/s41591-0…
rdcu.be/dOxQQ
Precision medicine requires finding people at a high risk of disease.
We used >3,000 proteins to develop sparse models for prediction of future risk of 218 diseases using #EHRs and #MachineLearning in @uk_biobank.
nature.com/articles/s41591-0…
rdcu.be/dOxQQ
We make our results available through our webserver (omicscience.org/apps/protpre…) to visualise the potential benefit of #proteomic screening in a Bayesian framework.
Amazing industry-academia collaboration with @Julia_Czs @pietznerm @jonathandavitte @profhhemingway @robert_a_scott and many others
@GSK @QMULBartsTheLon @UCL_IHI @MRC_epid @Cambridge_Uni
Outstanding scientists elected to EMBO Membership: in EMBO’s 60th anniversary year, 100 new members and 20 associate members join the community
embo.org/press-releases/outs…
We are so honoured for this recognition of our science. Go team!
Outstanding scientists elected to EMBO Membership: in EMBO’s 60th anniversary year, 100 new members and 20 associate members join the community
embo.org/press-releases/outs…
People with multiple diseases are prone to severe #Covid_19 and #LongCovid but which ones are most important and who did we miss?
We gathered >1,400 diseases in @uk_biobank using #EHRs to find out and triangulate with #Genetics
nature.com/articles/s43856-0…
However, known risk loci for #COVID_19 seem to behave oddly, ie., not always agree in direction of effect on highly related disease.
TYK2 challenges the popular genetically informed repurposing story of baricitinib (JAK-target); points to *adverse* effects of TYK2 inhibitors
Amazing collaboration with @SpirosDenaxas @pietznerm @_MatthiasArnold @KastenmullerLab
@berlinnovation @QMULBartsTheLon
@UCL_IHI







